Aurobindo Pharma: Completion Of US FDA Inspection At Raleigh Plant North Carolina Owned By Aurolife Pharma LLC A Wholly Owned Step-Down Subsidiary Of The Company | Value Research

Aurobindo Pharma: Completion Of US FDA Inspection At Raleigh Plant North Carolina Owned By Aurolife Pharma LLC A Wholly Owned Step-Down Subsidiary Of The Company

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 and further to our above referred letter this is to inform you that: The plant at Raleigh North Carolina USA owned by Aurolife Pharma LLC a wholly owned step-down subsidiary of the Company has received an establishment inspection report (EIR) mentioning the inspection a voluntary action initiated (VAI) from the United States Food and Drug Administration (US FDA) and with this the US FDA pre-approval inspection and GMP inspection are concluded.

Click here to view PDF


Other Categories